This page contains a Flash digital edition of a book.
Introduction


as well as contributing to the international process for assessing guidelines. The Human Fertilisation and Embryology Authority


(HFEA) regulates and inspects services that conduct in vitro fertilisation, artificial insemination and the storage of human eggs, sperm or embryos. At its inception, the HFEA was the first organisation of its type in the world, and led global thought in its approach to the complex ethical considerations surrounding the work it sought to regulate. The HFEA has been ground-breaking in its policy decisions compared with other similar organisations around the world, for example, work on stem cell research and the creation of the HFEA Horizon Scanning Expert Panel, drawn from international experts. The Human Tissue Authority (HTA) regulates


organisations that remove, store and use human tissue for research, medical treatment, post-mortem examination, education and training, and display in public. They also give approval for organ and bone marrow donations from living people. The regulation of human tissue by the HTA gives patients and their families more confidence that their wishes will be respected, that organs and tissue used in treatment will be safe and high quality; and that tissue used for research or other purposes will be put to the best possible use.


|


Regulations


is responsive to the changing needs of patients and communities and with resourcing decisions that are transparent, fair and efficient. Of course, it needs to ensure that the supply of professionally qualified clinical workforce is secure and safe to patients, but it also needs to consider how best to spread innovation across its health systems in order to improve quality of care.


The future: harnessing UK expertise to improve health systems and standards Over the last few decades the NHS has developed strong standards and governance within its integrated health system, giving sixty million citizens the assurance that their local provider will deliver safe, effective and equitable care, which demonstrates value for money for the taxpayer. The organisations described above, though not


exhaustive, serve to demonstrate how regulatory and supporting organisations ensure that each individual provider and professional is held to world- class standards of delivery, putting the patient at the centre of everything, whilst ensuring that quality, efficiency and equity are at the heart of the system. From the Care Quality Commission’s focus on


‘Over the last few decades the NHS has developed strong standards and governance within its integrated health system.’


By fostering this trust, the HTA hopes more people


will be willing to donate their tissue for scientific and medical research, their organs for transplants, and their bodies for medical education and training. It is in this way that the HTA can help healthcare to flourish.


Strategic planning and oversight Over fifty countries are experiencing an acute shortage of healthcare workers. The UK’s response to long-term workforce planning was to set up Health Education England (HEE), which, in addition to guaranteeing the future supply of health professionals to avoid any shortfalls, also works to bring consistency to the skills of carers, and to improve the education of health workers and make that education more responsive to emerging needs. The driving principle for reform of the education


and training system is to improve care and outcomes for patients and HEE exists for one reason alone – to help ensure delivery of the highest quality healthcare to England’s population. If a country wants to achieve this, it needs to show clear leadership when planning and developing its workforce, in a way that


26 Global Opportunity Healthcare 2015 | Issue 01


current quality, to Health Education England’s strategic management of the future healthcare workforce, UK healthcare providers are held to the highest standards of delivery and supported to develop successful and sustainable healthcare into the future. The NHS is built upon the principle that every


citizen deserves equal access to the best possible standards of healthcare; and the UK is therefore well placed to advise and support other countries in the strategic development of their health systems. Although not all of the organisations outlined


above are able to offer services in the immediate term, there exists a plethora of public and private organisations within the UK that have co-developed and learnt from these approaches and are able to assist international partners in establishing high- quality and accessible healthcare for their citizens. Healthcare UK’s key role is in helping international


partners access this expertise, having been established as a focal point for the formation of healthcare partnerships between UK organisations and healthcare providers around the world. As a joint initiative between the Department of Health UK Trade and Investment and NHS England, Healthcare UK has in-depth knowledge of the expertise available in the UK in both the NHS and the commercial sector. This means that it is also strategically placed to bring together consortia of UK organisations to deliver comprehensive solutions to healthcare requirements, however complex. Drawing on UK Trade and Investment’s network of professional advisors in over 100 countries, Healthcare UK works with governments and healthcare providers around the globe to co-develop healthcare solutions.


Further information www.gov.uk/healthcareuk


global-opportunity.co.uk


|


Regulations


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128